Alvaro Talavera
Hematology & Oncology · Carolina, PRNPI 1811985427
Payments from drug & device makers
Across 655 payments — averaging $26.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$2K
- Johnson & Johnson$2K
- Amgen$2K
- AstraZeneca$2K
- Rigel Pharmaceuticals, Inc.$2K
- R-pharm US LLC$1K
- plus $6K from 33 others
What the payments were for
- Speaking & faculty fees$2,37014%
- Food & beverage$14,16883%
- Education$5593%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 116 | $2,211 |
| Johnson & Johnson(2 entities) | 90 | $2,059 |
| Amgen | 66 | $2,016 |
| AstraZeneca | 92 | $1,698 |
| Rigel Pharmaceuticals, Inc. | 11 | $1,542 |
| R-pharm US LLC | 2 | $1,326 |
| Merck | 39 | $804 |
| Eli Lilly Export S.A. Puerto Rico Branch | 34 | $719 |
| AbbVie | 29 | $688 |
| PBG Puerto Rico LLC | 31 | $628 |
| Genentech USA, Inc. | 24 | $547 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $443 |
| Puma Biotechnology, Inc. | 18 | $340 |
| Novartis | 13 | $269 |
| Ipsen Biopharmaceuticals, Inc | 8 | $243 |
| Lilly USA, LLC | 9 | $227 |
| Incyte Corporation | 7 | $209 |
| Bayer | 11 | $206 |
| Taiho Oncology, Inc. | 10 | $197 |
| Sanofi | 8 | $160 |
| Clovis Oncology, Inc. | 3 | $64 |
| Gilead | 3 | $63 |
| Astellas Pharma US Inc | 3 | $57 |
| Verity Pharmaceuticals Inc. | 2 | $43 |
| Seagen Inc. | 2 | $39 |
| Exelixis Inc. | 2 | $37 |
| Jazz Pharmaceuticals Inc. | 2 | $33 |
| Bayer Puerto Rico Inc. | 1 | $30 |
| Tolmar, Inc. | 1 | $23 |
| Bristol Myers Squibb | 1 | $20 |
| Morphosys, US Inc. | 1 | $20 |
| Pfizer | 2 | $19 |
| Deciphera Pharmaceuticals Inc. | 1 | $19 |
| Spectrum Pharmaceuticals Inc. | 1 | $19 |
| Pfizer Pharmaceuticals LLC | 1 | $18 |
| Verastem, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Beigene USA, Inc. | 1 | $14 |
| Array Biopharma Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,097 in reported general payments places this provider in the 55th percentile of 138 hematology & oncology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZolinzaVorinostat | 12 | $59,436 |
| RetacritEpoetin Alfa-Epbx | 14 | $16,742 |
| Imatinib Mesylate | 13 | $5,186 |
| Hydroxyurea | 62 | $2,703 |
| Exemestane | 21 | $1,527 |
| Anastrozole | 88 | $1,137 |
| Bicalutamide | 18 | $806 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $239 |
| Cyanocobalamin InjectionCyanocobalamin (Vitamin B-12) | 16 | $106 |
| Gabapentin | 16 | $103 |
| Tramadol Hcl | 13 | $79 |
| Prednisone | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerRetacrit | $19 | $16,74214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 138 hematology & oncology providers in Puerto Rico.
Other hematology & oncology in Carolina
- Mirelis AcostaSan Juan$6.3M
- Hector Velez CortesPonce$3.1M
- Luis FloresSan Juan$2.3M
- Noridza Rivera RodriguezSan Juan$2.1M
- Adelba Torres-LopezSan Juan$1.9M
- Maria Garcia PallasCaguas$1.8M
- Karina Arocho-GonzalezHato Rey$1.1M
- Jose Lozada CostasSan Juan$934K
- Fernando CabanillasSan Juan$916K
- Mayra Rivera FigueroaRio Piedras$745K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.